J.M.P.G.M. de Vos

Verkolf, E. M. M., Dekker, E. N., van derGeest, L. G., Besselink, M. G., Bonsing, B. A., Bruno, M. J., Sarasqueta, A. F., de Hingh, I. H. J. T., Homs, M. Y. V., Jamieson, N. B., de Meijer, V. E., van Velthuysen, M. F., Verheij, J., de Vos-Geelen, J., de Wilde, R. F., Doukas, M., Koerkamp, B. G., & Dutch Pancreatic Cancer Group (2025). 10-year survival after resection of pancreatic ductal adenocarcinoma with pathological re-examination of a nationwide cohort. European Journal of Cancer, 231, Article 116099. https://doi.org/10.1016/j.ejca.2025.116099

Schafrat, P. J. M., van Erning, F. N., Zwinderman, K., Dekker, E., Farina Sarasqueta, A., de Vos-Geelen, J., Bouwense, S. A. W., Goedegebuure, R. S. A., Vermeulen, L., de Hingh, I. H. J. T., & Sommeijer, D. W. (2025). Malignancies of the small intestine: incidence and trends in a nationwide registry. Cancer Epidemiology, 99, Article 102943. https://doi.org/10.1016/j.canep.2025.102943

Kucukcelebi, S., van ‘t Land, F. R., van der Burg, S. H., Eskens, F. A. L. M., Homs, M. Y. V., Willemsen, M., Onrust-van Schoonhoven, A., Rozendaal, N. E. M., Fellah, A., Vadgama, D., Moskie, M., Bezemer, K., Doukas, M., van Eijck, C. W. F., Stadhouders, R., de Vos-Geelen, J., van Diepen, A. E., Enninga, I., Meijer, R., ... van Eijck, C. H. J. (2025). REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer. Nature Communications, 16(1), Article 10609. https://doi.org/10.1038/s41467-025-66092-1

Vissers, P. A. J., Elferink, M. A. G., Bijlsma, M. J., van der Geest, L. G., Koopman, M., van Laarhoven, H. W. M., Nieuwenhuijzen, G. A. P., van Rossum, P. S. N., Sijtsma, F. P. C., Vink, G. R., de Vos-Geelen, J., Wilmink, H. W., de Wilt, J. H. W., Verhoeven, R. H. A., & van Erning, F. N. (2025). Recommendations and definitions for time-to-event endpoints using real-world data in oncology. ESMO Real-World Data and Digital Oncology, 10, Article 100649. https://doi.org/10.1016/j.esmorw.2025.100649

Frenken, K. G., Chong, M. Y., Breukink, S. O., Janssen-Heijnen, M., Keulen, E. T. P., Konsten, J., Bijnens, W., Buffart, L. M., Meijer, K., Scheer, F. A. J. L., Steindorf, K., de Vos-Geelen, J., Weijenberg, M. P., Bours, M. J. L., & van Roekel, E. H. (2025). Longitudinal Associations of Sedentary Behavior and Physical Activity With Diurnal Rest-Activity Rhythms in Survivors of Colorectal Cancer Up to 5 Years Post-Treatment. Journal of Biological Rhythms, 40(6), 528-546. https://doi.org/10.1177/07487304251363674

Strijk, G. J., Van dongen, J. C., de koning, W., Brosens, L. A. A., Cirkel, G. A., Doukas, M., Sarasqueta, A. F., Groenendijk, F. H., Koerkamp, B. G., De hingh, I. H. J. T., Homs, M. Y. V., Martens-de Kemp, S. R., de Vos-Geelen, J., Wagner, A., Kooreman, N. G., Stubbs, A. P., Wilmink, J. W., van Eijck, C. H. J., & Dutch Pancreatic Canc Grp (2025). Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationwide prospective cohort study. European Journal of Cancer, 230, Article 116065. https://doi.org/10.1016/j.ejca.2025.116065

Luyten, J. A., van der Geest, L. G., Olde Damink, S. W. M., Schaap, F. G., Groot Koerkamp, B., Homs, M. Y. V., Erdmann, J. I., Brandts, W. F., Verheij, J., Hoogwater, F. J. H., Hagendoorn, J., Oor, J. E., Verdonk, R. C., Samarska, I. V., Miclea, R. L., Bednarsch, J., Neumann, U. P., de Vos-Geelen, J., & Dewulf, M. J. L. (2025). Outcomes following exploratory surgery without subsequent resection in perihilar cholangiocarcinoma: A nationwide analysis. European Journal of Surgical Oncology, 51(11), Article 110419. https://doi.org/10.1016/j.ejso.2025.110419

Hildebrand, N. D., Sier, M. A. T., van Kuijk, S. M. J., Hoeijmakers, L. S. M., Ackermans, L. L. G. C., Ubachs, J., Stassen, L., Ruber, N. F. M., Schaghen-D'Antonio, V., Goedegebuure, E. P., Baade-Corpelijn, L., Bongers, B. C., Stoot, J., Sosef, M., Lambrechts, S., de Vos van Steenwijk, P. J., Engelen, M., Lubbers, T., Blokhuis, T. J., ... Rensen, S. S. M. (2025). Patient-recorded indexing measurements (PRIMS) - study protocol of a prospective observational cohort study to improve the accuracy of the diagnosis of cancer cachexia. BMC Cancer, 25(1), Article 1572. https://doi.org/10.1186/s12885-025-14979-z

van der Geest, L. G., van der Mark, M., Verheij, J., Farina Sarasqueta, A., de Vos-Geelen, J., Besselink, M. G., de Meijer, V. E., de Hingh, I. H. J. T., Bonsing, B. A., de Reuver, P. R., Willemssen, F. E. J. A., Vissers, P. A. J., Visser, O., & Dutch Pancreatic Cancer Group and the Dutch Hepatocellular & Cholangiocarcinoma Group (2025). Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry. International Journal of Cancer. https://doi.org/10.1002/ijc.70145

Janssen, Q. P., van Dam, J. L., van Bekkum, M. L., Bonsing, B. A., Bos, H., Bosscha, K. P., Bouwense, S. A. W., Brouwer-Hol, L., Bruynzeel, A. M. E., Busch, O. R., Coene, P.-P. L. O., van Eijck, C. H. J., de Groot, J. W. B., Haberkorn, B. C. M., de Hingh, I. H. J. T., Karsten, T. M., Kazemier, G., van der Kolk, M. B., Liem, M. S. L., ... Dutch Pancreatic Cancer Group (2025). Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial. The Lancet Oncology, 26(10), 1346-1356. https://doi.org/10.1016/S1470-2045(25)00363-8